Skip to main content
. Author manuscript; available in PMC: 2026 Apr 1.
Published in final edited form as: Exp Neurol. 2024 May 25;378:114838. doi: 10.1016/j.expneurol.2024.114838

Figure 1.

Figure 1.

Schematic detailing of the two experimental designs. The infusion of anti-NMDAR antibodies and assessment of mouse behavior and histopathological changes during week 1 of antibody washout (A). The infusion of anti-NMDAR antibodies or control antibodies, administration of bromodeoxyuridine (BrdU), and assessment of mouse behavior and histopathological changes during weeks 3–4 of antibody washout (B). OF, open field; OL, object location; DCX, doublecortin; Prox-1, Prospero-related homeobox-1.